OXYGENTA PHARMACEUTICAL
Back to Cashflow Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹8.67 Cr | ₹17 Cr | ₹11 Cr | ₹6.33 Cr | ₹8.67 Cr |
What is the latest Cash Flow from Financing Activities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹8.67 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹6.33 Cr |
| Mar2021 | ₹8.67 Cr |
How is Cash Flow from Financing Activities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹8.67 Cr | -49.41 | |
| Mar2024 | ₹17 Cr | 52.64 | |
| Mar2023 | ₹11 Cr | 77.26 | |
| Mar2022 | ₹6.33 Cr | -26.94 | |
| Mar2021 | ₹8.67 Cr | - | |
Compare Cash Flow from Financing Activities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹206.4 Cr | -1% | -9.8% | -41.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,626.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,758.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,021.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| CIPLA | ₹122,046.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,086.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -1% |
-9.8% |
-41.2% |
| SENSEX | -1% |
-1.2% |
7.9% |
You may also like the below Video Courses